摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-4-methyl-6-ethyl-pyrimidine | 61233-53-2

中文名称
——
中文别名
——
英文名称
2-chloro-4-methyl-6-ethyl-pyrimidine
英文别名
2-Chloro-4-ethyl-6-methylpyrimidine
2-chloro-4-methyl-6-ethyl-pyrimidine化学式
CAS
61233-53-2
化学式
C7H9ClN2
mdl
MFCD18975574
分子量
156.615
InChiKey
QBZNYNDSHAHUFZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.428
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-chloro-4-methyl-6-ethyl-pyrimidine三异丙基硅烷N,N-二异丙基乙胺三氟乙酸 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 N-甲基吡咯烷酮二甲基亚砜N,N-二甲基甲酰胺 为溶剂, 反应 31.0h, 生成 1-[1-[(4-Ethyl-6-methylpyrimidin-2-yl)amino]-3-azabicyclo[3.2.0]heptan-3-yl]-2-(oxan-4-yl)ethanone
    参考文献:
    名称:
    通过[3 + 2]环加成合成3-氮杂双环[3.2.0]庚烷衍生的结构单元
    摘要:
    描述了通过环丁烯-1-羧酸酯和甲亚胺叶立德的[3 + 2]环加成反应合成3-氮杂双环[3.2.0]庚烷的结构单元。结果表明标题双环支架是一个三维模板,与基于铅的平行合成很好地兼容。
    DOI:
    10.1002/ejoc.201800972
点击查看最新优质反应信息

文献信息

  • Heterobicyclic metalloprotease inhibitors
    申请人:Gallagher M. Brian
    公开号:US20070155737A1
    公开(公告)日:2007-07-05
    The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic ADAMTS-4 inhibiting compounds.
    本发明通常涉及含有酰胺基团的药物,特别是含有酰胺基团的杂双环金属蛋白酶抑制剂化合物。更具体地,本发明提供了一类新的杂双环ADAMTS-4抑制剂化合物。
  • Pyrrolo-Pyridine, Pyrrolo-Pyrimidine and Related Heterocyclic Compounds
    申请人:Yuan Jun
    公开号:US20080267887A1
    公开(公告)日:2008-10-30
    Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds analogues of the formula: wherein R, R 2 , R 5 , E, Z 1 , Z 3 , Z 4 , and Ar are defined herein. Such compounds are ligands of C5a receptors. Preferred pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds of the invention bind to C5a receptors with high affinity and exhibit neutral antagonist or inverse agonist activity at C5a receptors. The present invention also relates to pharmaceutical compositions comprising such compounds, and to the use of such compounds in treating a variety of inflammatory, cardiovascular, and immune system disorders. In addition, the present invention provides labeled pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds, which are useful as probes for the localization of C5a receptors.
    吡咯吡啶、吡咯嘧啶和相关杂环化合物的类似物的公式如下: 其中R,R2,R5,E,Z1,Z3,Z4和Ar在此定义。这些化合物是C5a受体的配体。本发明所述的优选吡咯吡啶、吡咯嘧啶和相关杂环化合物以高亲和力结合到C5a受体,并在C5a受体上表现出中性拮抗剂或反向激动剂活性。本发明还涉及包含这些化合物的药物组合物,并且涉及使用这些化合物治疗各种炎症、心血管和免疫系统疾病。此外,本发明提供了标记的吡咯吡啶、吡咯嘧啶和相关杂环化合物,这些化合物可用作C5a受体的定位探针。
  • PYRROLO-PYRIDINE, PYRROLO-PYRIMIDINE AND RELATED HETEROCYCLIC COMPOUNDS
    申请人:Yuan Jun
    公开号:US20110118273A1
    公开(公告)日:2011-05-19
    Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds analogues of the formula: wherein R, R 2 , R 5 , E, Z 1 , Z 3 , Z 4 , and Ar are defined herein. Such compounds are ligands of C5a receptors. Preferred pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds of the invention bind to C5a receptors with high affinity and exhibit neutral antagonist or inverse agonist activity at C5a receptors. The present invention also relates to pharmaceutical compositions comprising such compounds, and to the use of such compounds in treating a variety of inflammatory, cardiovascular, and immune system disorders. In addition, the present invention provides labeled pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds, which are useful as probes for the localization of C5a receptors.
    吡咯并吡啶、吡咯并嘧啶和相关杂环化合物的类似物的公式为:其中R、R2、R5、E、Z1、Z3、Z4和Ar的定义如下。这些化合物是C5a受体的配体。本发明所述的优选吡咯并吡啶、吡咯并嘧啶和相关杂环化合物以高亲和力结合到C5a受体,并在C5a受体上表现出中性拮抗剂或反向激动剂活性。本发明还涉及包含这些化合物的制药组合物,以及使用这些化合物治疗各种炎症、心血管和免疫系统疾病的用途。此外,本发明提供了标记的吡咯并吡啶、吡咯并嘧啶和相关杂环化合物,这些化合物可用作C5a受体的定位探针。
  • Pyri(mi)dyl-oxy-und -thio-benzoesäure-Derivate
    申请人:BAYER AG
    公开号:EP0226837A2
    公开(公告)日:1987-07-01
    Die Erfindung betrifft Pyri(mi)dyl-oxy-bzw. -thio-benzoesäure-Derivate der Formel (I), in welcher R1, R2, R3, R4, A, B, Z, X, Y und n die in der Beschreibung angegebene Bedeutung haben, mehrere Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und/oder Wachstumsregulatoren.
    本发明涉及式(I)的吡(mi)二酰氧基或硫代苯甲酸衍生物、 其中 R1、R2、R3、R4、A、B、Z、X、Y 和 n 的含义,以及制备它们的多种工艺和它们作为除草剂和/或生长调节剂的用途。
  • Fungicide N-Cyclopropyl-Sulfonylamide Derivatives
    申请人:Schwarz Hans-Georg
    公开号:US20090137611A1
    公开(公告)日:2009-05-28
    The present invention relates to N-cyclopropyl-sulfonylamide derivatives of formula (I) wherein the substituents are cyclic groups, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions: (I)
查看更多